Franklin Genomic Advancements ETF (HELX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HELX | ||||
| Company | Franklin Genomic Advancements ETF | ||||
| Price Information | |||||
| Exchange | NYSE Arca | ||||
| Open | 33.88 | ||||
| High | 33.88 | ||||
| Low | 33.88 | ||||
| Latest | 33.88 | ||||
| Change | +0.23 | ||||
| % Change | +0.68% | ||||
| Volume | 100 | ||||
| 20-Day Average Volume | 565 | ||||
| Previous Close | 33.66 | ||||
| Industry | N/A | ||||
| Has Options | Yes | ||||
| Technicals | |||||
| 20-Day Moving Average | 34.66 | ||||
| 20-Day Raw Stochastic | 11.05% | ||||
| 20-Day Relative Strength | 38.42 | ||||
| Weighted Alpha | +17.74 | ||||
| Today's Opinion | 8% Buy | ||||
| Previous Opinion | 8% Sell | ||||
| Last Month's Opinion | 64% Buy | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.77% since 02/25/26 | ||||
| Low | 33.66 on 03/03/26 | ||||
| High | 34.75 on 02/26/26 | ||||
| 1-Month | |||||
| %Chg | -5.15% since 02/04/26 | ||||
| Low | 33.66 on 03/03/26 | ||||
| High | 35.66 on 02/05/26 | ||||
| 3-Month | |||||
| %Chg | -10.19% since 12/04/25 | ||||
| Low | 33.66 on 03/03/26 | ||||
| High | 38.17 on 01/07/26 | ||||
| 6-Month | |||||
| %Chg | +11.98% since 09/04/25 | ||||
| Low | 29.80 on 09/25/25 | ||||
| High | 38.17 on 01/07/26 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | 22,025 | ||||
| Shares Outstanding, K | 650 | ||||
| Annual Sales | 0 | ||||
| Annual Net Income | 0 | ||||
| Last Quarter Sales | N/A | ||||
| Last Quarter Net Income | N/A | ||||
| 60-Month Beta | 1.06 | ||||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | ||||
| Latest Earnings Date | N/A | ||||
| Most Recent Dividend | 0.143 on 12/30/25 | ||||
| Next Ex-Dividends Date | 12/30/25 | ||||
| Ratios | |||||
| Price/Earnings ttm | 30.44 | ||||